Cargando…
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
Multiple Sclerosis (MS) is a debilitating disease with typical onset between 20 and 40 years of age, so the disability associated with this disease, unfortunately, occurs in the prime of life. At a very early stage of MS, the relapsing-remitting mobility impairment occurs in parallel with a progress...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138270/ https://www.ncbi.nlm.nih.gov/pubmed/35625814 http://dx.doi.org/10.3390/biomedicines10051077 |